Breakthrough SARS-CoV-2 infections after vaccination: a critical review
At the beginning of the current pandemic, it was believed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection would induce lifelong immunity and that reinfections would be unlikely. However, after several cases of reinfection were documented in previously infected patients, t...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-11-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2022.2051412 |
| _version_ | 1797673208935088128 |
|---|---|
| author | Zeinab Mohseni Afshar Mohammad Barary Rezvan Hosseinzadeh Amirmasoud Alijanpour Dariush Hosseinzadeh Soheil Ebrahimpour Kosar Nazary Terence T. Sio Mark J. M. Sullman Kristin Carson-Chahhoud Arefeh Babazadeh |
| author_facet | Zeinab Mohseni Afshar Mohammad Barary Rezvan Hosseinzadeh Amirmasoud Alijanpour Dariush Hosseinzadeh Soheil Ebrahimpour Kosar Nazary Terence T. Sio Mark J. M. Sullman Kristin Carson-Chahhoud Arefeh Babazadeh |
| author_sort | Zeinab Mohseni Afshar |
| collection | DOAJ |
| description | At the beginning of the current pandemic, it was believed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection would induce lifelong immunity and that reinfections would be unlikely. However, after several cases of reinfection were documented in previously infected patients, this was understood to be a false assumption, and this waning humoral immunity has raised significant concerns. Accordingly, long-term and durable vaccine-induced antibody protection against infection have also become a challenge, as several breakthroughs of COVID-19 infection have been identified in individuals who were fully vaccinated. This review discusses the current evidence on breakthrough COVID-19 infections occurring after vaccination. |
| first_indexed | 2024-03-11T21:42:04Z |
| format | Article |
| id | doaj.art-cb348f55ed4e4155baa48c2ed236e4f9 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:42:04Z |
| publishDate | 2022-11-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-cb348f55ed4e4155baa48c2ed236e4f92023-09-26T13:19:05ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118510.1080/21645515.2022.20514122051412Breakthrough SARS-CoV-2 infections after vaccination: a critical reviewZeinab Mohseni Afshar0Mohammad Barary1Rezvan Hosseinzadeh2Amirmasoud Alijanpour3Dariush Hosseinzadeh4Soheil Ebrahimpour5Kosar Nazary6Terence T. Sio7Mark J. M. Sullman8Kristin Carson-Chahhoud9Arefeh Babazadeh10Kermanshah University of Medical SciencesShahid Beheshti University of Medical SciencesBabol University of Medical SciencesSemmelweis UniversityO. O. Bogomolets National Medical UniversityBabol University of Medical SciencesBabol University of Medical SciencesMayo ClinicUniversity of NicosiaUniversity of South AustraliaBabol University of Medical SciencesAt the beginning of the current pandemic, it was believed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection would induce lifelong immunity and that reinfections would be unlikely. However, after several cases of reinfection were documented in previously infected patients, this was understood to be a false assumption, and this waning humoral immunity has raised significant concerns. Accordingly, long-term and durable vaccine-induced antibody protection against infection have also become a challenge, as several breakthroughs of COVID-19 infection have been identified in individuals who were fully vaccinated. This review discusses the current evidence on breakthrough COVID-19 infections occurring after vaccination.http://dx.doi.org/10.1080/21645515.2022.2051412sars-cov-2breakthroughvaccinationcovid-19immunization |
| spellingShingle | Zeinab Mohseni Afshar Mohammad Barary Rezvan Hosseinzadeh Amirmasoud Alijanpour Dariush Hosseinzadeh Soheil Ebrahimpour Kosar Nazary Terence T. Sio Mark J. M. Sullman Kristin Carson-Chahhoud Arefeh Babazadeh Breakthrough SARS-CoV-2 infections after vaccination: a critical review Human Vaccines & Immunotherapeutics sars-cov-2 breakthrough vaccination covid-19 immunization |
| title | Breakthrough SARS-CoV-2 infections after vaccination: a critical review |
| title_full | Breakthrough SARS-CoV-2 infections after vaccination: a critical review |
| title_fullStr | Breakthrough SARS-CoV-2 infections after vaccination: a critical review |
| title_full_unstemmed | Breakthrough SARS-CoV-2 infections after vaccination: a critical review |
| title_short | Breakthrough SARS-CoV-2 infections after vaccination: a critical review |
| title_sort | breakthrough sars cov 2 infections after vaccination a critical review |
| topic | sars-cov-2 breakthrough vaccination covid-19 immunization |
| url | http://dx.doi.org/10.1080/21645515.2022.2051412 |
| work_keys_str_mv | AT zeinabmohseniafshar breakthroughsarscov2infectionsaftervaccinationacriticalreview AT mohammadbarary breakthroughsarscov2infectionsaftervaccinationacriticalreview AT rezvanhosseinzadeh breakthroughsarscov2infectionsaftervaccinationacriticalreview AT amirmasoudalijanpour breakthroughsarscov2infectionsaftervaccinationacriticalreview AT dariushhosseinzadeh breakthroughsarscov2infectionsaftervaccinationacriticalreview AT soheilebrahimpour breakthroughsarscov2infectionsaftervaccinationacriticalreview AT kosarnazary breakthroughsarscov2infectionsaftervaccinationacriticalreview AT terencetsio breakthroughsarscov2infectionsaftervaccinationacriticalreview AT markjmsullman breakthroughsarscov2infectionsaftervaccinationacriticalreview AT kristincarsonchahhoud breakthroughsarscov2infectionsaftervaccinationacriticalreview AT arefehbabazadeh breakthroughsarscov2infectionsaftervaccinationacriticalreview |